Combined checkpoint immunotherapy and cytotoxic chemotherapy: Further results from a phase Ib/II trial of pembrolizumab and docetaxel or gemcitabine in patients with advanced or metastatic urothelial cancer

被引：1
|
作者：
Parikh, Mamta
Pan, Chong-xian
Beckett, Laurel
Li, Yueju
Robles, Daniel
DeVisser, Christina
Lara, Primo
机构：
[1] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA
[2] UC Davis Hlth, Comprehens Canc Ctr, Sacramento, CA USA
[3] Univ Calif Davis, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4541
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Paclitaxel and carboplatin in patients with metastatic urothelial cancer:: Results of a phase II trial
    Zielinski, CC
    Schnack, B
    Grbovic, M
    Brodowicz, T
    Wiltschke, C
    Steger, G
    Pflüger, H
    Marberger, M
    BRITISH JOURNAL OF CANCER, 1998, 78 (03) : 370 - 374
  • [22] First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial
    Abdulmuthalib
    Darwis, Idral
    Prayogo, Nugroho
    Sutjipto
    MEDICAL JOURNAL OF INDONESIA, 2005, 14 (01) : 20 - 25
  • [23] Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial
    CC Zielinski
    B Schnack
    M Grbovic
    T Brodowicz
    C Wiltschke
    G Steger
    H Pflüger
    M Marberger
    British Journal of Cancer, 1998, 78 : 370 - 374
  • [24] Phase II trial of weekly docetaxel/gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancer
    O'Shaughnessy, Joyce A.
    Pluenneke, Robert
    Sternberg, Jack
    Khandelwal, Pankaj
    Ilegbodu, Des
    Asmar, Lina
    CLINICAL BREAST CANCER, 2006, 6 (06) : 505 - 510
  • [25] Phase Ib/II Trial of Gemcitabine, Cisplatin, and Lenalidomide as First-Line Therapy in Patients With Metastatic Urothelial Carcinoma
    Agarwal, Neeraj
    Apolo, Andrea B.
    Tsao, Che-Kai
    Lee, Karen M.
    Godbold, James H.
    Soto, Rothschild
    Poole, Austin
    Gimpel-Tetra, Kiev
    Lowe, Nancy
    Oh, William K.
    Galsky, Matthew D
    ONCOLOGIST, 2014, 19 (09): : 915 - 916
  • [26] Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients
    R de Wit
    WHJ Kruit
    G Stoter
    M de Boer
    J Kerger
    J Verweij
    British Journal of Cancer, 1998, 78 : 1342 - 1345
  • [27] Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients
    de Wit, R
    Kruit, WHJ
    Stoter, G
    de Boer, M
    Kerger, J
    Verweij, J
    BRITISH JOURNAL OF CANCER, 1998, 78 (10) : 1342 - 1345
  • [28] Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
    Ishikawa, Takeshi
    Kokura, Satoshi
    Sakamoto, Naoyuki
    Ando, Takashi
    Imamoto, Eiko
    Hattori, Takeshi
    Oyamada, Hirokazu
    Yoshinami, Naomi
    Sakamoto, Masafumi
    Kitagawa, Kazutomo
    Okumura, Yoko
    Yoshida, Naohisa
    Kamada, Kazuhiro
    Katada, Kazuhiro
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Yasuda, Hiroaki
    Sakagami, Junichi
    Konishi, Hideyuki
    Yagi, Nobuaki
    Naito, Yuji
    Yoshikawa, Toshikazu
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2012, 28 (07) : 597 - 604
  • [29] Phase Ib/II Study of Pembrolizumab plus Chemotherapy in Advanced Cancer: Results of Lung Cancer Patients Receiving ≥ 1 Prior Line of Therapy
    Weiss, Glen J.
    Barndt, Heather
    Blaydorn, Lisa
    Sangal, Ashish
    Khemka, Vivek
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S742 - S743
  • [30] Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma - Results of a phase II trial
    Dragovich, Tomislav
    Burris, Howard, III
    Loehrer, Patrick
    Von Hoff, Daniel D.
    Chow, Sherry
    Stratton, Steven
    Green, Sylvan
    Obregon, Yrma
    Alvarez, Irene
    Gordon, Michael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 157 - 162
12345